Ghisallo Capital Management »

4d Molecular Therapeutics In shares owned by Ghisallo Capital Management

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Ghisallo Capital Management from 13F filings

Historical chart of Ghisallo Capital Management investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Ghisallo Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Ghisallo Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $318k 25k 12.73
2023-06-30 $452k 25k 18.07

More positions owned by Ghisallo Capital Management

Rollins (ROL)
Aercap Holdings Nv SHS (AER)
Arm Holdings Sponsored Adr (ARM)
Enbridge (ENB)
Kenvue (KVUE)
Alibaba Group Hldg Sponsored Ads (BABA)
Ge Healthcare Technologies I Common Stock (GEHC)
PG&E Corporation (PCG)
Jd.com Spon Adr Cl A (JD)
Core & Main Cl A (CNM)
Nextracker Class A Com (NXT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Corebridge Finl (CRBG)
Carlyle Group (CG)

View all positions for Ghisallo Capital Management

Top funds holding 4d Molecular Therapeutics In

Viking Global Investors
RA Capital Management
BVF
VR Adviser
Henderson Group
Vanguard Group
Arrowpoint Asset Management
Casdin Capital
Goldman Sachs Group
Dimensional Fund Advisors
Deutsche Bank Aktiengesellschaft
Eagle Health Investments
Assenagon Asset Management
Jpmorgan Chase & Co
Point72 Asset Management

View all funds holding 4d Molecular Therapeutics In